Now available: R&D Briefing 53: Availability of new medicines – Characterising the factors influencing drug roll out to six markets and
R&D Briefing 54: New drug approvals in ICH countries 2004-2013.
2014 Activities Schedule
Comparing HTA recommendations for 9 European jurisdictions; from Allen et al, poster, ISPOR, Beijing, 2014.
Slide of the Month Archive •>
© 2014 CIRS (Centre for Innovation in Regulatory Science)